↓ Skip to main content

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects

Overview of attention for article published in Frontiers in Pharmacology, February 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 20,615)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
96 news outlets
blogs
2 blogs
twitter
36 X users
facebook
1 Facebook page

Readers on

mendeley
160 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
Published in
Frontiers in Pharmacology, February 2020
DOI 10.3389/fphar.2020.00063
Pubmed ID
Authors

Christopher S. Pauli, Matthieu Conroy, Brian D. Vanden Heuvel, Sang-Hyuck Park

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 160 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 16%
Student > Master 20 13%
Student > Bachelor 19 12%
Student > Ph. D. Student 14 9%
Other 11 7%
Other 16 10%
Unknown 55 34%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 11%
Medicine and Dentistry 17 11%
Pharmacology, Toxicology and Pharmaceutical Science 17 11%
Agricultural and Biological Sciences 9 6%
Chemistry 9 6%
Other 25 16%
Unknown 65 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 778. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2024.
All research outputs
#26,651
of 26,601,484 outputs
Outputs from Frontiers in Pharmacology
#8
of 20,615 outputs
Outputs of similar age
#873
of 387,433 outputs
Outputs of similar age from Frontiers in Pharmacology
#1
of 528 outputs
Altmetric has tracked 26,601,484 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,615 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,433 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 528 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.